These results suggest that even among a predominantly CU sample, Aβ+ is associated with abnormal atrophy in brain regions consistent with an AD-like pattern of atrophy that may worsen with longer exposure to abnormal Aβ accumulation independently of tau. Here, MAPT is linked to Alzheimer disease.